StonvexLoading…
StonvexStonvexStonvexCore line items from ERII's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $134.99M | $144.95M | $128.35M | $125.59M |
Operating Income | $23.89M | $19.72M | $19.05M | $24.83M |
Net Income | $22.96M | $23.05M | $21.50M | $24.05M |
EPS (Diluted) | $0.42 | $0.40 | $0.37 | $0.42 |
Total Assets | $231.51M | $242.79M | $252.97M | $217.04M |
Total Liabilities | $25.32M | $32.78M | $33.17M | $31.70M |
Cash & Equivalents | $48.08M | $29.63M | $68.10M | $56.35M |
Free Cash Flow OCF − CapEx | $17.44M | $19.22M | $23.49M | $8.40M |
Shares Outstanding | 52.81M | 54.79M | 56.88M | 56.08M |